Cargando…
Multitargeted Imidazoles: Potential Therapeutic Leads for Alzheimer’s and Other Neurodegenerative Diseases
[Image: see text] Alzheimer’s disease (AD) is a complex, multifactorial disease in which different neuropathological mechanisms are likely involved, including those associated with pathological tau and Aβ species as well as neuroinflammation. In this context, the development of single multitargeted...
Autores principales: | Cornec, Anne-Sophie, Monti, Ludovica, Kovalevich, Jane, Makani, Vishruti, James, Michael J., Vijayendran, Krishna G., Oukoloff, Killian, Yao, Yuemang, Lee, Virginia M.-Y., Trojanowski, John Q., Smith, Amos B., Brunden, Kurt R., Ballatore, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483893/ https://www.ncbi.nlm.nih.gov/pubmed/28530811 http://dx.doi.org/10.1021/acs.jmedchem.7b00475 |
Ejemplares similares
-
A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model
por: Zhang, Bin, et al.
Publicado: (2018) -
Evaluation of the brain-penetrant microtubule-stabilizing agent, dictyostatin, in the PS19 tau transgenic mouse model of tauopathy
por: Makani, Vishruti, et al.
Publicado: (2016) -
Microtubule-Stabilizing
1,2,4-Triazolo[1,5-a]pyrimidines as Candidate
Therapeutics for Neurodegenerative
Disease: Matched Molecular Pair Analyses and Computational Studies
Reveal New Structure–Activity Insights
por: Alle, Thibault, et al.
Publicado: (2022) -
Brain-Penetrant, Orally Bioavailable
Microtubule-Stabilizing
Small Molecules Are Potential Candidate Therapeutics for Alzheimer’s
Disease and Related Tauopathies
por: Lou, Kevin, et al.
Publicado: (2014) -
Multitarget Therapeutics for Neurodegenerative Diseases
por: Gabr, Moustafa T., et al.
Publicado: (2020)